Subacute Prurigo or Bullous Pemphigoid: Diagnostic Challenges Arising From Narrowband UVB Therapy

BACKGROUND: Phototherapy is widely used in dermatology and is generally safe, but it may occasionally trigger other dermatoses, including immune-mediated bullous diseases. Bullous pemphigoid (BP) is characterized by subepidermal blisters and autoantibodies against hemidesmosomal antigens and is diagnosed by histopathology and immunofluorescence. BP often has a prolonged prodromal phase with pruritus, excoriated papules, and urticaria-like plaques. DATA SOURCES: Clinical, histopathological, and immunofluorescence findings in a patient who developed bullous pemphigoid following narrowband ultraviolet B phototherapy for subacute prurigo. MAIN FINDINGS AND LIMITATIONS: A patient who had been undergoing narrowband ultraviolet B phototherapy for a provisional diagnosis of subacute prurigo subsequently presented with generalized pruritus, which was found to be due to the development of bullous pemphigoid (BP). In cases of subacute prurigo-even when histopathological findings do not support a diagnosis of BP-one should remain vigilant for underlying BP, as UV exposure may trigger its onset. Existing literature supports this observation and our specific case. The limitations of this report include the fact that it is based on a single case and that measurements of BP180 and BP230 antibodies could not be performed. CONCLUSIONS: Patients undergoing phototherapy for pruritic dermatoses should may warrant monitoring for clinical features suggestive of BP. In patients with atypical or treatment-refractory pruritus, direct immunofluorescence and serologic testing for anti-BP180 and anti-BP230 antibodies should be considered.

Authors

Institutions

Publication Details

Journal
American Journal of Therapeutics
Published
2026-11-20
DOI
https://doi.org/10.1097/mjt.0000000000002262
Primary Topic
Autoimmune Bullous Skin Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Subacute Prurigo or Bullous Pemphigoid: Diagnostic Challenges Arising From Narrowband UVB Therapy

Selami Aykut Temiz, Fahriye Kılınç, Hasan Emre İlgenli, Adnan Semiz
American Journal of Therapeutics
Autoimmune Bullous Skin Diseases
article

Subacute Prurigo or Bullous Pemphigoid: Diagnostic Challenges Arising From Narrowband UVB Therapy

Selami Aykut Temiz, Fahriye Kılınç, Hasan Emre İlgenli, Adnan Semiz
article en

Abstract

BACKGROUND: Phototherapy is widely used in dermatology and is generally safe, but it may occasionally trigger other dermatoses, including immune-mediated bullous diseases. Bullous pemphigoid (BP) is characterized by subepidermal blisters and autoantibodies against hemidesmosomal antigens and is diagnosed by histopathology and immunofluorescence. BP often has a prolonged prodromal phase with pruritus, excoriated papules, and urticaria-like plaques. DATA SOURCES: Clinical, histopathological, and immunofluorescence findings in a patient who developed bullous pemphigoid following narrowband ultraviolet B phototherapy for subacute prurigo. MAIN FINDINGS AND LIMITATIONS: A patient who had been undergoing narrowband ultraviolet B phototherapy for a provisional diagnosis of subacute prurigo subsequently presented with generalized pruritus, which was found to be due to the development of bullous pemphigoid (BP). In cases of subacute prurigo-even when histopathological findings do not support a diagnosis of BP-one should remain vigilant for underlying BP, as UV exposure may trigger its onset. Existing literature supports this observation and our specific case. The limitations of this report include the fact that it is based on a single case and that measurements of BP180 and BP230 antibodies could not be performed. CONCLUSIONS: Patients undergoing phototherapy for pruritic dermatoses should may warrant monitoring for clinical features suggestive of BP. In patients with atypical or treatment-refractory pruritus, direct immunofluorescence and serologic testing for anti-BP180 and anti-BP230 antibodies should be considered.

American Journal of Therapeutics
Necmettin Erbakan University (TR)
Good health and well-being
Autoimmune Bullous Skin Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon